Eligibility Details:
Inclusion Criteria:
- Participant is an adult male between the ages of 20-30 years
- Participant is aerobically fit, as defined by a VO2max between 42-70 ml*kg/min
(determined by the screening test)
- Participant is not obese (18.5 ≦ BMI < 30 kg/m²)
- Participant has provided written and dated informed consent to participate in the
study
- Participant is willing and able to comply with the protocol
- Participant is apparently healthy and free from disease, as determined by a health
history questionnaire
- Participant agrees to refrain from strenuous exercise and alcohol consumption within
24 hours of laboratory visits, and to refrain from caffeine consumption within twelve
hours of visits
- Participant agrees to refrain from using antibacterial mouthwash, chewing gum, and
brushing their teeth on the morning of laboratory visits
Exclusion Criteria:
- Participant has consistently used prescription drugs or ergogenic dietary supplements
that may influence study outcomes within eight weeks prior to enrollment, or begins to
do so during the study. Potential drugs and supplements include but are not limited to
whey protein, creatine, beta-alanine, antihypertensive medications, or anabolic
steroids
- Participant has gained or lost ≥10 lbs in the previous 2 months
- Participant is enrolled in a separate clinical trial involving diet, exercise,
physical activity, or the potential ingestion of an active drug or dietary supplement
in the previous 2 months and during this study
- Participant has participated in a clinical trial within the previous 2 months that
includes modifications to their physical and/or diet that may influence study outcomes
and during this study
- Participant has a known allergy or sensitivity to the placebo or active ingredients
- Participant consumes more than 3 alcoholic drinks per day
- Participant has used tobacco more than three days per week (on average) in the
previous eight weeks
- Participant has used recreational drugs within the past month, or refuses to abstain
from recreational drug use for the entirety of the study